Cameron Stephenson is a Shareholder with Levin Papantonio Rafferty, have joined the Firm in 2009.
Mr. Stephenson has received several multimillion-dollar verdicts and settlements in the areas of product liability, wrongful death, personal injury and medical malpractice.
Mr. Stephenson's current practice is primarily focused in Mass Tort pharmaceutical and medical device litigation. He is actively involved in several pending Multi-District Litigations (MDLs), including Johnson & Johnson Talcum Powder/Ovarian Cancer (MDL No. 2738) and Proton Pump Inhibitor/Kidney Disease (MDL No. 2789).
